Opinions
Jim Cramer - Mad Money
ARS Pharmaceuticals
SPRY-Q
RISKY
Apr 22, 2024
N/A
Stock price when the opinion was issued
Pharma & Healthcare
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
Speculative, but we need more pharma companies to make immunotherapy drugs.